Technology
Biology Technology
| 12/17/2009 | NEW HAVEN, Conn., Dec. 17 Prometheus Research, a leading provider of web-enabled database software for biomedical researchers, has been awarded a $136,500 National Science Foundation grant to create a working, web-enabled database software prototype that can be installed and configured at low cost, with minimal support, and is easy to use. The National Sci... [Comments] |
| 12/17/2009 | BEIJING, Dec. 17 /PRNewswire-Asia/ -- Using a novel stem cell basedtechnology of Cellonis Biotechnologies, Beijing, a Chinese research/medicalteam may eliminate a glioma -- brain cancer -- of a 36 year old Norwegianpatient in a hospital in Beijing. The treatment shows that the activatedimmune system can directly kill tumor stem cells as well as cancer daughterce... [Comments] |
Reportlinker Adds Infectious Disease Molecular Diagnostic Testing
| 12/17/2009 | NEW YORK, Dec. 17 Reportlinker.com announces that a new market research report is available in its catalogue: Infectious Disease Molecular Diagnostic Testing http://www.reportlinker.com/p0170008/Infectious-Disease-Molecular-Diagnostic-Testing.html The report presents an overview of the clinical significance and market needs for ma... [Comments] |
Novus Biologicals Awards Contract to Biovista Inc. to Drive its Web-Based Novus Explorer Service
| 12/17/2009 | CHARLOTTESVILLE, Virginia, December 17 Biovista Inc.today announced the signing of a contract with Novus Biologicals for accessto Biovista's BEA literature mining platform. BEA will be used to power NovusExplorer, a new service that Novus Biologicals is offering to visitors of itsweb site. Driven by BEA, Novus Explorer will allow site visitors to identify... [Comments] |
Osteotech Submits 510(k) Application to FDA for Clearance of its Duratech(TM) BioRegeneration Matrix
| 12/17/2009 | EATONTOWN, N.J., Dec. 17 Osteotech, Inc. (Nasdaq: OSTE ), a leader in the emerging field of biologic products for regenerative healing, announced today that it has submitted a 510(k) application to the United States Food and Drug Administration (FDA) to obtain marketing clearance for the use of its Duratech(TM) BioRegeneration Matrix to repair or replace th... [Comments] |
YM BioSciences Inc. and Therapure Biopharma Inc. Announce Contract
| 12/17/2009 | - Therapure Biopharma to perform fill/finish of nimotuzumab - MISSISSAUGA, ON, Dec. 17 /PRNewswire-FirstCall/ - David Allan, Chairman and CEO of YM BioSciences Inc. and Thomas Wellner, President and CEO of Therapure Biopharma Inc. today announced the signing of an agreement under which Therapure Biopharma will provide fill and finish services for nimotuzumab, the humanized mon... [Comments] |
| 12/17/2009 | BEIJING, Dec. 17 /PRNewswire-Asia/ -- Using a novel stem cell basedtechnology of Cellonis Biotechnologies, Beijing, a Chinese research/medicalteam may eliminate a glioma -- brain cancer -- of a 36 year old Norwegianpatient in a hospital in Beijing. The treatment shows that the activatedimmune system can directly kill tumor stem cells as well as cancer daughterce... [Comments] |
| 12/17/2009 | PricewaterhouseCoopers’ Health Research Institute's Top 10 Health Industry Issues in 2010, puts healthcare cost control at the head of the list as the overarching theme for the year ahead. New York, NY (Vocus) December 17, 2009 -- Pricew... [Comments] |  |
| 12/17/2009 | Healthcare employment continued to rise the U.S. in November, even as the overall unemployment rate edged down slightly. Additionally, there were no unexpected major job cuts in the pharmaceutical industry. (Vocus) December 17, 2009 -- Novembe... [Comments] |  |
Website Redesign Enhances Global Health Screening Service's Online Presence
| 12/17/2009 | A revamped website from Cleveland-based Life Line Screening allows users to easily find and schedule an appointment for a local health screening, learn what to expect at a health screening, share comments, view personal stories, and connect with the company via Facebook,... [Comments] |  |
Goble & Associates Creative Work Awarded at Advertising Industry Competitions
| 12/17/2009 | Honors from the Rx Club, the Daveys, the GLOBALS, and PM360 Pharma Choice Awards Programs. (PRWEB) December 17, 2009 -- Chicago-based full-service healthcare communications agency Goble & Associates, Inc. (G&A) recently received recogni... [Comments] |  |
Medicine Technology
Amnis to Present at the 28th Annual J.P. Morgan Healthcare Conference
| 12/17/2009 | SEATTLE, Dec. 17 Amnis Corporation, a manufacturer of advanced cell imaging systems, announced today that the company will present at the 28th Annual J.P. Morgan Healthcare Conference. The Conference will be held January 11-14 at the Westin St. Francis Hotel in San Francisco. David Basiji, Ph.D., Amnis' President and Chief Executive Officer, will present on Tuesday, J... [Comments] |
Revolutionary Radiation Monitoring Device for CT Scans
| 12/17/2009 | SANDWICH, Mass., Dec. 17 Just how much exposure to radiation from CT scans is too much and how do those working with patients in the CT scan environment and their patients protect themselves from over exposure? Veteran-owned RADeCO Health, Inc. of Sandwich, Ma. ( www.radecohealth.com ) today announced the launch of the RADView(TM) CT dosimeter, a new monitoring devi... [Comments] |
| 12/17/2009 | OMAHA, Neb., Dec. 17 Transgenomic, Inc. (OTC Bulletin Board: TBIO) announced today that it has reached agreement with Gene Solutions for an exclusive licensing option to a set of validated mutations found in Parkinson's disease patients that can form the basis of a novel and accurate diagnostic test for Parkinson's disease. Transgenomic's platform mitochondr... [Comments] |
Beckman Coulter Affirms 2009 Outlook
| 12/17/2009 | ORANGE COUNTY, Calif., Dec. 17 Beckman Coulter, Inc. (NYSE: BEC ), a leading developer, manufacturer and marketer of products that simplify, automate and innovate complex biomedical testing, today affirmed its 2009 outlook and provided preliminary outlook for 2010. (Logo: http://www.newscom.com/cgi-bin/prnh/20031202/BECLOGO ) Scott Garr... [Comments] |
Pitcher Joaquin Benoit, PADF Team Up to Send a Much-Needed Christmas Present to Haiti's Hospitals
| 12/17/2009 | WASHINGTON, Dec. 17 Major League Baseball pitcher and former Texas Rangers Joaquin Benoit is adding new meaning to the word "relief" this Christmas for thousands of Haitians. Benoit responded to the Pan American Development Foundation's (PADF) request for cash assistance that allows the non-profit to deliver hospital equipment to areas in Haiti tha... [Comments] |
| 12/17/2009 | EMERYVILLE, Calif., Dec. 17 Neurobiological Technologies, Inc. (formerly NTII) ("NTI") announced today that it filed a Certificate of Dissolution with the Secretary of State of the State of Delaware on December 17, 2009. Certificates of Dissolution generally become effective upon filing. The Certificate of Dissolution provides for the dissolution of NTI under the Del... [Comments] |
| 12/17/2009 | CVS/pharmacy and the New York State Fraternal Order of Police help Easter Seals New York host the largest Community Outreach yet PORT JERVIS, N.Y., Dec. 17 On Monday, December 14th, CVS/pharmacy, the New York State Fraternal Order of Police and dozens of volunteers came together at Easter Seals New York's Child Development Center, Project Discov... [Comments] |
| 12/17/2009 | FLUSHING, N.Y., Dec. 17 A 58-year-old man who lives in Corona, Queens came to the emergency room of New York Hospital Queens (NYHQ) with extreme pain and tingling in his left arm. Although he did not realize it at the time, he had lung cancer. Recently, he made medical history as the first patient in the United States to be treated for lung cancer throug... [Comments] |
Nominations Open for the 2010 Dr. Paul Janssen Award for Biomedical Research
| 12/17/2009 | NEW BRUNSWICK, N.J., Dec. 17 The Dr. Paul Janssen Award for Biomedical Research has opened the 2010 call for nominations. The $100,000 Award recognizes individuals whose efforts have made significant transformational contributions towards the improvement of human health. Nomination forms are available at pauljanssenaward.com and will be accepted until February 15,... [Comments] |
Vion Pharmaceuticals Files for Chapter 11 Bankruptcy
| 12/17/2009 | NEW HAVEN, Conn., Dec. 17 VION PHARMACEUTICALS, INC. (OTC Bulletin Board: VION), a pharmaceutical company focused on the development of novel cancer therapeutics, announced that it had voluntarily filed for bankruptcy under Chapter 11 of the United States Bankruptcy Code in the United States Bankruptcy Court for the District of Delaware. Vion is contin... [Comments] |
| 12/17/2009 | MCHENRY, Ill., Dec. 17 Medela announced today the award recipients from its November Virtual Human Milk (breastmilk) Collection Campaign in honor of the March of Dimes' National Prematurity Awareness Month. More than 4,100 participated in the campaign, voting for their preferred Neonatal Intensive Care Unit. Each of the following hospitals will receive $5,000 in neona... [Comments] |
(Date:12/17/2009)... Top 10 Health Industry Issues in 2010, puts healthcare cost control ... the year ahead. , ... New York, NY ... Top 10 Health Industry Issues in 2010, puts healthcare ... overarching theme for the year ahead. , , , , ,“Healthcare ...
(Date:12/17/2009)... the latest particle size distribution technologies, including the new C35 ... AAPS 2010. , ... (PRWEB) December ... American Association of Pharmaceutical Scientists’ Annual Meeting, AAPS 2010 ... Booth 612 at AAPS 2010 to see the latest particle ...
(Date:12/16/2009)... of East Anglia (UEA) could contribute to the development ... generate clean electricity. , Published today by the leading ... Sciences (PNAS), the researchers have demonstrated for the ... by ,breathing rocks,. , The findings could be applied ... such as fuel cells, or ,bio-batteries, powered by animal ...
(Date:12/16/2009)... Corporation (Nasdaq: MATK ) today announced its financial ... October 31, 2009. Revenues for the fourth quarter were ... fourth quarter of fiscal 2008. Net income was $11.0 ... quarter of fiscal 2009, a 5% increase compared with ... year,s fourth quarter. The fourth quarter of fiscal ...
Breaking Biology Technology:Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 2Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 3Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 4Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010, 5Particle Size Distribution Technologies at American Association of Pharmaceutical Scientists (AAPS) Annual Meeting 2010 2'Rock-breathing' bacteria could generate electricity and clean up oil spills 2Martek Announces Fourth Quarter and FY 2009 Financial Results 2Martek Announces Fourth Quarter and FY 2009 Financial Results 3Martek Announces Fourth Quarter and FY 2009 Financial Results 4Martek Announces Fourth Quarter and FY 2009 Financial Results 5Martek Announces Fourth Quarter and FY 2009 Financial Results 6Martek Announces Fourth Quarter and FY 2009 Financial Results 7Martek Announces Fourth Quarter and FY 2009 Financial Results 8Martek Announces Fourth Quarter and FY 2009 Financial Results 9Martek Announces Fourth Quarter and FY 2009 Financial Results 10Martek Announces Fourth Quarter and FY 2009 Financial Results 11Martek Announces Fourth Quarter and FY 2009 Financial Results 12Martek Announces Fourth Quarter and FY 2009 Financial Results 13Martek Announces Fourth Quarter and FY 2009 Financial Results 14[0] Squeezing Costs out of Healthcare Tops PricewaterhouseCoopers' List of Health Industry Issues in 2010,[0] Particle Size Distribution Technologies at American Association of Pharmaceutical Scientists (AAPS) Annual Meeting 2010[0] 'Rock-breathing' bacteria could generate electricity and clean up oil spills[0] Martek Announces Fourth Quarter and FY 2009 Financial Results
... SERIES Episode #9 - HEART DISEASE September 19, 2007, NEW YORK, Sept. ... upcoming episode of the Charlie Rose Science Series will ... cause of mortality worldwide. A ... biology and genetics of the disease, prevention and treatment, the ...
... HAMBURG, Germany, Sept. 14 Indivumed announces today,that ... signed. Within,this agreement Indivumed will apply its automated ... targets in the,area of oncology. Indivumed will provide ... from its tumor biobank as well as specifically,collected ...
... Inc. (Nasdaq: HGSI ) announced today that its ... Conference in London,will be webcast and may be accessed ... ) A member of Human Genome Sciences, senior ... Tuesday, September 18, 2007 at 2:20 pm London,Time, or ...
Other Biology Technology:Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United States 2Panel to Discuss the Far-Ranging Effects and Consequences of Heart Disease, Which is the Leading Killer in Both Men and Women in the United StatesIndivumed Supports Roche Diagnostics With Immunohistochemistry Services and Clinical Specimens for Biomarker Discovery and Drug DevelopmentHuman Genome Sciences Invites Investors to Listen to Webcast of Presentation at Merrill Lynch Conference
(Date:12/17/2009)... Decision Resources, one of the world,s leading research ... finds that the cost of Roche/Chugai,s Avastin, followed ... are cited most frequently by surveyed oncologists as ... non-small-cell lung cancer treatment in Germany, France, Italy, ... Special European Physician & Payer Forum report entitled ...
(Date:12/17/2009)... ORLANDO, Fla., Dec. 17 MedX Limited, ... -branded medical exercise equipment and a subsidiary of ... the sale of 227 MedX exercise ... list of countries, including Australia, Germany, India, Scotland, ... sold MedX equipment will be used ...
(Date:12/17/2009)... Inc., (OTC Bulletin Board: SCIE) disclosed today that its ... letter to shareholders: ,, As the end of the ... the recent closing of a $4.3 million round of ... ramping our business performance as we head into 2010. ... force. We are increasing our sales and marketing activities ...
Breaking Medicine Technology:Surveyed European Oncologists Cite Cost Most Frequently as the Factor Preventing Their Use of Avastin for Non-Small-Cell Lung Cancer 2Surveyed European Oncologists Cite Cost Most Frequently as the Factor Preventing Their Use of Avastin for Non-Small-Cell Lung Cancer 3WellTek Subsidiary MedX Limited Increases Presence in Global Market 2WellTek Subsidiary MedX Limited Increases Presence in Global Market 3WellTek Subsidiary MedX Limited Increases Presence in Global Market 4SpectraScience Releases Shareholder Newsletter 2SpectraScience Releases Shareholder Newsletter 3SpectraScience Releases Shareholder Newsletter 4SpectraScience Releases Shareholder Newsletter 5Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 1Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 2Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 3Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 4Purple Communications Dream Bigger Initiative Honors Cancer Survivor and Deaf Community Activist as Trailblazer 5110 5Abbott Cuts Use of Oil and Coal by 35 Percent 5108 1Abbott Cuts Use of Oil and Coal by 35 Percent 5108 2Abbott Cuts Use of Oil and Coal by 35 Percent 5108 3Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth 5106 1Clifford Chance Advises Pfizer on Conditional Clearance in China of Its Merger with Wyeth 5106 2... — SciClone,Pharmaceuticals, Inc. (NASDAQ: SCLN) today announced that ... Meeting of,the American Society of Clinical Oncology in ... (thymalfasin, thymosin alpha 1) Poster,Presentation ,A large first-line, ... (T?1) plus Dacarbazine (DTIC) with or without,Interferon alpha ...
... WIRE)--Apr 30, 2007 - Insmed Inc.,(Nasdaq:INSM) today ... clinical study of the company's drug,IPLEX(TM) in ... (HARS)., Preliminary results from the study, being ... showed that three months,of 0.5 mg/kg/day IPLEX ...
Other Medicine Technology:SciClone Announces ZADAXIN and SCV-07 Abstracts Accepted at ASCO 2Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 2Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 3Insmed Releases Positive Results from Iplex Phase II HIV-Associated,Adipose Redistribution Syndrome Clinical Study 4| Copyright © 2003-2009 Bio-Medicine. All rights reserved. ABOUT | CONTACT US | DISCLAIMER | PRIVACY POLICY | TERMS AND CONDITIONS |  |